Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein

被引:93
作者
Yuan, KH
Yi, L
Chen, J
Qu, XX
Qing, TT
Rao, X
Jiang, PF
Hu, JH
Xiong, ZK
Nie, YC
Shi, XL
Wang, W
Ling, C
Yin, XL
Fan, KQ
Lai, LH
Ding, MX
Deng, HK [1 ]
机构
[1] Peking Univ, Coll Life Sci, Dept Genet & Cell Biol, Beijing 100871, Peoples R China
[2] Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China
基金
中国国家自然科学基金;
关键词
SARS-CoV; entry inhibitor; peptides; spike protein; pseudotyped virus;
D O I
10.1016/j.bbrc.2004.05.046
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Heptad repeat regions (HR1 and HR2) are highly conserved sequences located in the glycoproteins of enveloped viruses. They form a six-helix bundle structure and are important in the process of virus fusion. Peptides derived from the HR regions of some viruses have been shown to inhibit the entry of these viruses. SARS-CoV was also predicted to have HR1 and HR2 regions in the S2 protein. Based on this prediction, we designed 25 peptides and screened them using a HIV-luc/SARS pseudotyped virus assay. Two peptides, HR1-1 and HR2-18, were identified as potential inhibitors, with EC50 values of 0.14 and 1.19 muM, respectively. The inhibitory effects of these peptides were validated by the wild-type SARS-CoV assay. HR1-1 and HR2-18 can serve as functional probes for dissecting the fusion mechanism of SARS-CoV and also provide the potential of further identifying potent inhibitors for SARS-CoV entry. (C) 2004 Published by Elsevier Inc.
引用
收藏
页码:746 / 752
页数:7
相关论文
共 34 条
  • [1] Membrane fusion mediated by coiled coils: A hypothesis
    Bentz, J
    [J]. BIOPHYSICAL JOURNAL, 2000, 78 (02) : 886 - 900
  • [2] The coronavirus spike protein is a class I virus fusion protein: Structural and functional characterization of the fusion core complex
    Bosch, BJ
    van der Zee, R
    de Haan, CAM
    Rottier, PJM
    [J]. JOURNAL OF VIROLOGY, 2003, 77 (16) : 8801 - 8811
  • [3] Identification of a novel coronavirus in patients with severe acute respiratory syndrome
    Drosten, C
    Günther, S
    Preiser, W
    van der Werf, S
    Brodt, HR
    Becker, S
    Rabenau, H
    Panning, M
    Kolesnikova, L
    Fouchier, RAM
    Berger, A
    Burguière, AM
    Cinatl, J
    Eickmann, M
    Escriou, N
    Grywna, K
    Kramme, S
    Manuguerra, JC
    Müller, S
    Rickerts, V
    Stürmer, M
    Vieth, S
    Klenk, HD
    Osterhaus, ADME
    Schmitz, H
    Doerr, HW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (20) : 1967 - 1976
  • [4] The hydrophobic pocket contributes to the structural stability of the N-terminal coiled coil of HIV gp41 but is not required for six-helix bundle formation
    Dwyer, JJ
    Hasan, A
    Wilson, KL
    White, JM
    Matthews, TJ
    Delmedico, MK
    [J]. BIOCHEMISTRY, 2003, 42 (17) : 4945 - 4953
  • [5] Mechanisms of viral membrane fusion and its inhibition
    Eckert, DM
    Kim, PS
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 2001, 70 : 777 - 810
  • [6] HONG Z, 2004, IN PRESS J VIROL
  • [7] A NEW APPROACH FOR MEASUREMENT OF CYTOTOXICITY USING COLORIMETRIC ASSAY
    HUSSAIN, RF
    NOURI, AME
    OLIVER, RTD
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1993, 160 (01) : 89 - 96
  • [8] Inhibition of HIV-1 infection by an intramolecular antisense peptide to T20 in gp160
    Imai, M
    Okada, N
    Okada, H
    [J]. MICROBIOLOGY AND IMMUNOLOGY, 2000, 44 (03) : 205 - 212
  • [9] Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry
    Kilby, JM
    Hopkins, S
    Venetta, TM
    DiMassimo, B
    Cloud, GA
    Lee, JY
    Alldredge, L
    Hunter, E
    Lambert, D
    Bolognesi, D
    Mathews, T
    Johnson, MR
    Nowak, MA
    Shaw, GM
    Saag, MS
    [J]. NATURE MEDICINE, 1998, 4 (11) : 1302 - 1307
  • [10] Cloaked similarity between HIV-1 and SARS-CoV suggests an anti-SARS strategy
    Kliger, Y
    Levanon, EY
    [J]. BMC MICROBIOLOGY, 2003, 3 (1) : 1 - 7